Microbot Medical (MBOT) vs Myomo (MYO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Myomo (MYO) has outperformed Microbot Medical (MBOT) over the past year, gaining 23.3% versus a loss of 66.2%. Over five years, MBOT leads with a -85.1% price change compared with -89.3% for MYO. Microbot Medical is the larger company by market cap ($71.9 million vs $56.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MBOT | MYO |
|---|---|---|
| Share price | $1.07 | $1.43 |
| Market cap | $71.87M | $56.64M |
| 1-day change | 0.00% | +1.42% |
| YTD return | -46.50% | +57.14% |
| 1-year return | -66.25% | +23.28% |
| 5-year return | -85.08% | -89.28% |
| EPS (TTM) | $-0.25 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.04 | $1.89 |
| 52-week low | $1.05 | $0.605 |
| Distance from 52-week high | -64.80% | -24.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +491.59% | +224.48% |
| Average volume | 653.62K | 496.01K |
| Shares outstanding | 67.16M | 39.61M |
| Employees | 43 | 194 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MYO has outperformed MBOT by 89.5 percentage points over the past year.
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Health Care · Medical/Dental Instruments · 43 employees
About Myomo
MYO stock →Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Health Care · Industrial Specialties · 194 employees
MBOT vs MYO FAQ
Which is bigger, Microbot Medical or Myomo?
Microbot Medical (MBOT) is larger, with a market capitalization of $71.87M compared with $56.64M for Myomo (MYO).
Which stock has performed better over the past year, MBOT or MYO?
MYO returned +23.28% over the past 12 months, compared with -66.25% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are Microbot Medical and Myomo in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Microbot Medical and Industrial Specialties for Myomo.